UNI-EN 82:CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDING 30 JUNE 2015
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 82 | / | 2015 | | ||||||
Date of issue: | 2015-08-28 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDING 30 JUNE 2015 | |||||||||||
Official market - legal basis | |||||||||||
Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieї№ce i okresowe | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDING 30 JUNE 2015 1. Financial Statements 2. Notes to the Financial Statements 3. Management report 4. Templates of the financial reports approved by the Bulgarian FSC 5. Declaration | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
SFARM CONSO 30.06.2015.zip SFARM CONSO 30.06.2015.zip | CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDING 30 JUNE 2015 |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2015-08-28 | Ognian Donev | Executive diirector |
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 5.5 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.